The Human Insulin Analog Aspart Can Induce Insulin Allergy

Diabetes Care- United States

doi 10.2337/diacare.27.8.2084-a

Full Text

Abstract

Available in

Date

Authors

Publisher

American Diabetes Association

Related search

Insulin Degludec Aspart: The First Co-Formulation of Insulin Analogues

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Insulin Aspart Reduziert Kardiovaskuläre Ereignisse

MMW Fortschritte der Medizin
Medicine
2016German

INSULIN ASPART CAN LEAD MEIOTIC RESUMPTION IN CATFISH, Clarias Grapienus OOCYTES

Jurnal Kedokteran Hewan - Indonesian Journal of Veterinary Sciences
2013English

Besser Und Kostengünstiger Mit Insulin Aspart

MMW Fortschritte der Medizin
Medicine
2017German

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Comparison of a Soluble Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart 30 in Type 2 Diabetes: A Randomised Trial

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2012English

Initiation of Biphasic Insulin Aspart in a Patient Failing Basal Insulin Treatment

European Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2010English

Use of Fast‐acting Insulin Aspart in Insulin Pump Therapy in Clinical Practice

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Safety, Immunogenicity and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People With Diabetes Also Using Insulin Glargine: 12-Month Results From the GEMELLI 1 Trial

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy